HIV/AIDS - Publications - Faculty & Research - Harvard Business School

Filter Results: (49)

Filter Results: (49)

Show Results For

Page 1 of 49 Results →

Sort by

Are you looking for?

→Search All HBS Web

October 2020 (Revised April 2022)
Case

When Institutions Fail: HIV/AIDS in the 1980s

By: Tom Nicholas and Christian Godwin

During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting... View Details

September 2012
Case

SCMS: Battling HIV/AIDS in Africa

By: Ananth Raman, Noel Watson, Santiago Kraiselburd and Emmanuel Akili

In 2005, USAID and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), created the Supply Chain Management System (SCMS) to procure and distribute essential medicines and supplies; provide technical assistance to transform existing supply chains; and... View Details

February 2003 (Revised May 2003)
Case

AngloGold - Corporate Responsibility for HIV/AIDS (D)

Supplements the (A) case. View Details

Find at Harvard

February 2003 (Revised May 2003)
Case

AngloGold - Corporate Responsibility for HIV/AIDS (B)

Supplements the (A) case. View Details

Find at Harvard

January 2003 (Revised May 2003)
Case

AngloGold - Corporate Responsibility for HIV/AIDS (A)

AngloGold, a South African gold-mining corporation, faces a decision to provide its workforce, 30% of which is infected with HIV, with antiretroviral treatment. View Details

Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Mining Industry; South Africa

Find at Harvard

January 2003 (Revised May 2003)
Case

Heineken NV: Workplace HIV/AIDS Programs in Africa (C)

Third in a three-part series that explores the multifaceted organizational and strategic choices that companies now face as a result of the global AIDS epidemic. Heineken is considering becoming one of the first companies to offer AIDS drugs (antiretroviral therapy) to... View Details

Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Food and Beverage Industry; Africa

February 2003 (Revised May 2003)
Case

AngloGold - Corporate Responsibility for HIV/AIDS (C)

Supplements the (A) case. View Details

Find at Harvard

03 Apr 2009
Working Paper Summaries

Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings

Keywords: by Joseph Rhatigan, Sachin Jain, Joia S. Mukherjee & Michael E. Porter; Health

2009
Working Paper

Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings

By: Joseph Rhatigan, Sachin H Jain, Joia S. Mukherjee and Michael E. Porter

The care delivery value chain is a framework that can help conceptualize the organization and structure of care delivery for medical conditions. We apply this framework to HIV/AIDS care in resource-limited settings. Several conclusions arise than can help inform... View Details

Keywords: Customer Value and Value Chain; Framework; Health Care and Treatment; Health Disorders; Service Delivery

January 2003 (Revised May 2003)
Case

Heineken NV: Workplace HIV/AIDS Programs in Africa (A)

This case is the first in a three-part series that explores the multifaceted organizational and strategic choices that companies now face as a result of the global AIDS epidemic. Heineken is considering becoming one of the first companies to offer AIDS drugs... View Details

Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Food and Beverage Industry; Africa

August 2008 (Revised September 2009)
Case

Sex, Drugs, and Rock 'n Roll: The MTV Approach to Tackling HIV/AIDS

By: Tarun Khanna, Sonali R. Bloom and David E. Bloom

This case explores the role that MTV, with its heavy diet of music and general youth-oriented media content, plays in spreading public-service messaging to contain the scourge of HIV/AIDS worldwide. There is a focus especially on its efforts in several emerging... View Details

Keywords: For-Profit Firms; Developing Countries and Economies; Multinational Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Corporate Strategy; Health Industry; Africa

January 2003 (Revised May 2003)
Case

Heineken NV: Workplace HIV/AIDS Programs in Africa (B)

Second in a three-part series that explores the multifaceted organizational and strategic choices that companies now face as a result of the global AIDS epidemic. Heineken is considering becoming one of the first companies to offer AIDS drugs (antiretroviral therapy)... View Details

Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Food and Beverage Industry; Africa

June 2005 (Revised March 2007)
Case

ACHAP (African Comprehensive HIV/AIDS Partnerships): the Merck/Gates Initiative in Botswana

By: V. Kasturi Rangan

By June 2004, ACHAP, a three-way partnership of The Bill and Melinda Gates Foundation, Merck, and the Botswana government, had committed nearly $60 million of the $100 million toward various AIDS education, prevention, and treatment programs. It was time to evaluate... View Details

Keywords: Business or Company Management; Growth and Development Strategy; Social Marketing; Corporate Social Responsibility and Impact; Performance Evaluation; Business and Government Relations; Partners and Partnerships; Health Industry

Find at Harvard

January 2002
Case

Global Business Council on HIV/AIDS on World AIDS Day 2001, The

Explores the motivation for businesses to be concerned with the global AIDS epidemic. The formation of the council serves as an example of how business leaders are building a network of companies to develop an effective business response to AIDS-both through workforce... View Details

Keywords: Health; Social Issues; Global Strategy; Business and Community Relations; Growth and Development Strategy; Business and Government Relations; Health Industry

July 31, 2017
Article

A Commitment Contract to Achieve Virologic Suppression in Poorly Adherent Patients with HIV/AIDS

By: Marcella Alsan, John Beshears, Wendy S. Armstrong, James J. Choi, Brigitte C. Madrian, Minh Ly T. Nguyen, Carlos Del Rio, David Laibson and Vincent C. Marconi

Objective: Assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence. Design: Single-center pilot randomized clinical trial and a... View Details

Keywords: Adherence; Antiretroviral Therapy; Behavioral Economics; Commitment Contract; Financial Incentives; HIV-1 Virologic Suppression; Health Disorders; Motivation and Incentives

Find at Harvard

March 2009
Teaching Note

Sex, Drugs, and Rock 'n Roll: The MTV Approach to Tackling HIV/AIDS (TN)

By: Tarun Khanna, Sonali R. Bloom and David E. Bloom

Teaching Note for [709429]. View Details

Keywords: Advertising; Emerging Markets; Health Pandemics; Announcements; Social Issues; Customers; For-Profit Firms; Business Strategy; Infrastructure; Multinational Firms and Management; Music Industry; Entertainment and Recreation Industry; Africa

November 2020 (Revised April 2021)
Technical Note

Tales of Life-changing Innovations: Containing a Fearsome Pandemic | Note on the Development of HIV/AIDS Controls, Tests, and Treatments (through 2000)

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins

April 2011 (Revised April 2015)
Case

Cipla 2011

By: Rohit Deshpande, Sandra J. Sucher and Laura Winig

Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape. View Details

Keywords: Leadership; Leading Change; Leadership Style; Management Teams; Governance Compliance; Corporate Strategy; Pharmaceutical Industry

21 Jan 2013
Research & Ideas

Altruistic Capital: Harnessing Your Employees’ Intrinsic Goodwill

collaborate on a field experiment with Ashraf and two colleagues, Oriana Bandiera of the London School of Economics and Kelsey Jack of Tufts University. SFH had established a new program in which hairdressers provided HIV/AIDS education... View Details

Keywords: by Carmen Nobel

January 2001
Case

Merck Global Health Initiatives (A)

By: James E. Austin, Diana Barrett and James Weber

The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details

Keywords: Programs; Philanthropy and Charitable Giving; Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Pharmaceutical Industry; Botswana

1
2
3
→